NASDAQ:ROIV
Roivant Sciences Ltd. Stock Company Profile
$11.21
+0.310 (+2.84%)
At Close: May 01, 2024
Information
11-12 St. James’s Square, Suite 1, 3rd Floor
London SW1Y 4LB
44 2074 003 347
roivant.com
Industry: Biotechnology
Sector: Healthcare
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
